Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofogliflozin with GLP-1 Analogue in Type 2 Diabetes Mellitus
NCT02537834Phase 4Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Aug 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Kowa Company, Ltd.. Started Aug 2015; status: completed.
02
Drugs
tofogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02537834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537834.